- Profile
- Personal Information
- Publications
Experts in Clinical Research
Anna Akinshina Elizabeth R. Dumont Alexander R. Gerson Dr. Sateesh B Arja Anita Airee Peter J. Embi N. Elagovan Shaun Grannis Dr. Patricia Rhynders Beulah Shekha Johanne Eliacin Bert van der Zwaan Frank Caligiuri Renae Chesnut Cheryl Clarke Andrew Miesner Dr. David Amor Thomas Felzmann Avihu Boneh John Carlin View MoreDavid S. Block
President and CEO
Autoimmune Disease and Cancer
gliknik
United States of America
David founded Gliknik in 2007 after 17 years in industry, 12 of which were in a series of commercial positions at DuPont Merck and DuPont Pharmaceuticals including sales management, licensing, R&D portfolio planning, market development, and product launch. He was the EVP of International Operations at the time of the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb. From 2002 to 2004, David was the Chief Operating Officer of Celera Genomics. Prior to founding Gliknik, he formed and ran a venture-backed CNS start-up. David received his M.D. and M.B.A. at the University of Pennsylvania and was board-certified in Internal Medicine before entering the biopharmaceutical industry.
Autoimmune Disease and Cancer, Research and Development